Methodological issues in tardive dyskinesia research

Schizophrenia Bulletin
H A Nasrallah

Abstract

Research into tardive dyskinesia, an involuntary movement disorder secondary to chronic neuroleptic treatment, has so far produced conflicting results with no clear clinical applications. Heterogeneous diagnostic criteria, research designs, and rating scales, plus an emphasis on single-drug trials, are probably responsible. A strategy of developing pharmacological response profiles for patients participating in tardive dyskinesia research is suggested as one way to produce meaningful data, which may delineate pharmacological and clinical subtypes that would respond to different treatment approaches. Further suggestions are made about future trends in this area of research.

Citations

Jul 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·P L Herrling, B Misbach-Lesenne
Feb 1, 1985·Biological Psychiatry·H A NasrallahM McCalley-Whitters
Dec 1, 1981·Psychiatry Research·J C GillinW E Bunney
Aug 1, 1984·Psychological Medicine·H A NasrallahA D Sherman
Aug 1, 1983·Artificial Organs·W T CarpenterA A Kurland
Jan 1, 1997·European Psychiatry : the Journal of the Association of European Psychiatrists·J van OsR Murray
Aug 26, 2020·Journal of the International Neuropsychological Society : JINS·Laura B ZahodneAdam M Brickman
Jan 1, 1984·Scandinavian Journal of Infectious Diseases. Supplementum
Jul 1, 1983·Drug Intelligence & Clinical Pharmacy·S S WeberP Mastrati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here